A CRL and other hurdles ahead for Axsome Therapeutics’s migraine treatment, AXS-07
On April 25, Axsome Therapeutics revealed that chemistry, manufacturing and controls (CMS) issues were identified during the US Food and…
By
On April 25, Axsome Therapeutics revealed that chemistry, manufacturing and controls (CMS) issues were identified during the US Food and…
ByThe Omicron-specific vaccine was found to be safe and effective in animals in preclinical research.
The initial portion of the trial will assess increasing doses of the NK1R+ MSCs in adult patients.
NICE’s approval of Forxiga (dapagliflozin) suggests the drug has some advantages over existing chronic kidney disease treatments.
ByThe improvement of PaO2/FiO2 ratio greater than or equal to 100mmHg will be the trial’s primary endpoint.
GlobalData anticipates substantial uptake of Vraylar as an adjunctive treatment of major depressive disorder (MDD).
ByTenapanor has the potential to be an alternative therapy option to traditional phosphate binders, while also offering a smaller pill…
ByGlobalData believes that Roche’s bid to revive tominersen is justifiable given the acute unmet needs in the Huntington’s market.
By